Aileron Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results

    NEXT STORY
    Spero Therapeutics Announces Fourth Quarter and Full Year 2017 Operating Results and Provides Pipeline Update
    PREV STORY
    Depomed Announces the Appointment of Stan Bukofzer, M.D. as Senior Vice President and Chief Medical and Scientific Officer
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Fortress Biotech Announces Pricing of Series A Preferred Stock Offering

    author_avatar
    NASDAQ Market News

    Nuclear Medicine/Radiopharmaceutical Global Market – Forecast To 2027

    author_avatar
    NASDAQ Market News

    MERIT MEDICAL RECEIVES TWO ADDITIONAL FDA BREAKTHROUGH DEVICE DESIGNATIONS

    author_avatar
    NASDAQ Market News